Sample size and interim analysis issues for dose selection.
Lee
K L
KL
Duke Clinical Research Institute, Durham, NC 27715, USA.
D015982:Bias; D002317:Cardiovascular Agents / Q000008:administration & dosage* / Q000009:adverse effects; D017322:Clinical Trials, Phase II as Topic / Q000706:statistics & numerical data*; D017326:Clinical Trials, Phase III as Topic / Q000706:statistics & numerical data*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data*; D018401:Sample Size
D002317:Cardiovascular Agents